Search

everythinglearnresearchcommunity

for

Search:↓

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Paroxetine relieves pain by increasing allopregnanolone levels.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

Liquid nitrogen spray caused a temporary, harmless swelling under the skin in an elderly woman.

The document concludes that Loose Anagen Hair Syndrome is a benign condition where hair is thin and easily pulled out, often improving with age.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

TRPA1 and TRPV1 channels don't affect mechanotransduction in rat sinus hair follicles.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.

Some dibenzo compounds might help treat cancer with fewer side effects.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

Aromoline and DRD4 are potential targets for osteoarthritis treatment.

Men and women react differently to opioids, with hormones potentially influencing these differences.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Finding functions for unknown GPCRs is hard but key for making new drugs.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Morphine increases testosterone breakdown in the rat brain and spinal cord.

In late pregnancy, allopregnanolone reduces stress responses in rats by affecting brain chemicals.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

Targeting neurosteroids may help prevent drug relapse.

Progesterone and allopregnanolone increase glycine release in rat brain cells.

Neurosteroids may help treat disorders with too much dopamine activity.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

New treatment improves male hair loss.